Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Haluska

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Adjuvant interferon for stage II melanomaF G Haluska
The Oncologist|February 13, 2001
Interferon in oncological practice: review of interferon biology, clinical applications, and toxicitiesE Jonasch, F G Haluska
Annals of the New York Academy of Sciences|January 1, 1987
Molecular mechanisms of chromosome translocation in human B- and T-cell neoplasiaF G Haluska, C M Croce
Nature|January 4, 1987
More clues to gene rearrangementsF G Haluska, C M Croce
Cancer Surveys|January 1, 1995
Recent advances in the molecular genetics of malignant melanomaF G Haluska, D E Housman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Molecular genetics of familial cutaneous melanomaF G Haluska, F S Hodi
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MelanomaF G Haluska, P S Multani
Nucleic Acids Research|March 25, 1988
The t(8;14) breakpoint of the EW 36 undifferentiated lymphoma cell line lies 5' of MYC in a region prone to involvement in endemic Burkitt's lymphomasF G Haluska, Y Tsujimoto, C M Croce
Annual Review of Genetics|January 1, 1987
Oncogene activation by chromosome translocation in human malignancyF G Haluska, Y Tsujimoto, C M Croce
Nucleic Acids Research|January 26, 1987
p380-8A 1.8 SaSs, a single copy clone 5' of c-myc at 8q24 which recognizes an SstI polymorphismF G Haluska, K Huebner, C M Croce
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Adjuvant interferon for stage II melanomaF G Haluska
The Oncologist|February 13, 2001
Interferon in oncological practice: review of interferon biology, clinical applications, and toxicitiesE Jonasch, F G Haluska
Annals of the New York Academy of Sciences|January 1, 1987
Molecular mechanisms of chromosome translocation in human B- and T-cell neoplasiaF G Haluska, C M Croce
Nature|January 4, 1987
More clues to gene rearrangementsF G Haluska, C M Croce
Cancer Surveys|January 1, 1995
Recent advances in the molecular genetics of malignant melanomaF G Haluska, D E Housman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Molecular genetics of familial cutaneous melanomaF G Haluska, F S Hodi
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MelanomaF G Haluska, P S Multani
Nucleic Acids Research|March 25, 1988
The t(8;14) breakpoint of the EW 36 undifferentiated lymphoma cell line lies 5' of MYC in a region prone to involvement in endemic Burkitt's lymphomasF G Haluska, Y Tsujimoto, C M Croce
Annual Review of Genetics|January 1, 1987
Oncogene activation by chromosome translocation in human malignancyF G Haluska, Y Tsujimoto, C M Croce
Nucleic Acids Research|January 26, 1987
p380-8A 1.8 SaSs, a single copy clone 5' of c-myc at 8q24 which recognizes an SstI polymorphismF G Haluska, K Huebner, C M Croce
Pageof 5